HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Khadega A Abuelgasim Selected Research

Dexamethasone (Maxidex)

4/2020Venetoclax in combination with carfilzomib and dexamethasone in relapsed/refractory multiple myeloma harboring t(11,14)(q13;q32): two case reports and a review of the literature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Khadega A Abuelgasim Research Topics

Disease

4Hodgkin Disease (Hodgkin's Disease)
01/2021 - 01/2019
3Neoplasms (Cancer)
02/2024 - 03/2018
3Lymphoma (Lymphomas)
02/2024 - 04/2020
2Hematologic Neoplasms (Hematological Malignancy)
01/2023 - 04/2020
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 05/2016
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
03/2018 - 05/2016
1Lung Neoplasms (Lung Cancer)
02/2024
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2023
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2023
1Sickle Cell Anemia (Hemoglobin S Disease)
12/2021
1Tuberculosis (Tuberculoses)
09/2021
1Primary Myelofibrosis (Myelosclerosis)
09/2021
1Fibrosis (Cirrhosis)
09/2021
1Opportunistic Infections (Opportunistic Infection)
09/2021
1Osteosclerosis
09/2021
1Plasma Cell Leukemia
04/2020
1Multiple Myeloma
04/2020
1Disease Progression
04/2020
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2018
1Anemia
03/2018
1Thrombocytopenia (Thrombopenia)
03/2018
1Trisomy (Trisomies)
03/2018
1Leukemia
08/2017
1Blast Crisis (Blast Phase)
05/2016
1Hypoxia (Hypoxemia)
01/2013
1Polycythemia (Erythrocytosis)
01/2013
1Hypoglycemia (Reactive Hypoglycemia)
01/2013

Drug/Important Bio-Agent (IBA)

3Brentuximab VedotinIBA
01/2021 - 01/2019
1Indicators and Reagents (Reagents)IBA
02/2024
1Immunoglobulin M (IgM)IBA
01/2023
1Phosphotransferases (Kinase)IBA
09/2021
1ruxolitinibIBA
09/2021
1Interleukin-12 (IL 12)IBA
09/2021
1CytokinesIBA
09/2021
1Interleukin-6 (Interleukin 6)IBA
09/2021
1InterferonsIBA
09/2021
1Interleukin-1 (Interleukin 1)IBA
09/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2021
1Rituximab (Mabthera)FDA Link
01/2021
1venetoclaxIBA
04/2020
1carfilzomibIBA
04/2020
1Lenalidomide (CC 5013)FDA Link
04/2020
1Dexamethasone (Maxidex)FDA LinkGeneric
04/2020
1Immunoglobulin G (IgG)IBA
04/2020
1IgA receptor (protein B)IBA
04/2020
1Vinorelbine (Navelbine)FDA LinkGeneric
01/2019
1IfosfamideFDA LinkGeneric
01/2019
1GemcitabineFDA Link
01/2019
1purineIBA
03/2018
1Imatinib Mesylate (Gleevec)FDA Link
03/2018
1fludarabineIBA
03/2018
1Tyrosine Kinase InhibitorsIBA
05/2016
1Dasatinib (BMS 354825)FDA Link
05/2016
1Proteins (Proteins, Gene)FDA Link
01/2013
1Insulin (Novolin)FDA Link
01/2013
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2013
1Glucose (Dextrose)FDA LinkGeneric
01/2013
1EnzymesIBA
01/2013

Therapy/Procedure

9Therapeutics
01/2023 - 05/2016
2Hematopoietic Stem Cell Transplantation
12/2021 - 12/2020
2Complementary Therapies (Alternative Medicine)
06/2021 - 03/2018
2Drug Therapy (Chemotherapy)
04/2020 - 05/2016
1Transplantation
01/2021
1Precision Medicine
04/2020
1Cell Transplantation
08/2017
1Induction Chemotherapy
05/2016